John Pacifico joined Canaan's healthcare venture team at age 20 and has since served as CEO of two biosurgical companies (ORTHOCON and Abyrx) that he helped launch from the investor side, giving him hands-on company-building experience alongside traditional venture investing. He has also invented medical products that achieved FDA clearance for surgical use and helped lead fundraising for multiple Canaan vehicles, bringing more than $1.75B of capital into the firm. John Pacifico joined Canaan's healthcare venture team at age 20 and has since served as CEO of two biosurgical companies (ORTHOCON and Abyrx) that he helped launch from the investor side, giving him hands-on company-building experience alongside traditional venture investing. He has also invented medical products that achieved FDA clearance for surgical use and helped lead fundraising for multiple Canaan vehicles, bringing more than $1.75B of capital into the firm.